BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36915750)

  • 1. Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1.
    Huang C; Wang M; Zhao WY; Shen YY; Zhuang C; Ni B; Yang LX; Lu L; Li XQ; Tu L; Cao H
    Am J Transl Res; 2023; 15(2):1026-1040. PubMed ID: 36915750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer.
    Cao S; Lin L; Xia X; Wu H
    Mol Ther Nucleic Acids; 2019 Sep; 17():455-464. PubMed ID: 31330497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
    J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
    Jin J; Chu Z; Ma P; Meng Y; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
    Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
    J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
    Li Z; Tang X; Duan S
    Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition.
    Cui F; Wu D; He X; Wang W; Xi J; Wang M
    Tumour Biol; 2016 Aug; 37(8):10871-6. PubMed ID: 26883252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.
    Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL
    J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
    Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
    Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
    Liu H; Lv Z; Guo E
    Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on the Role of SPRY4-IT1 in the Carcinogenesis.
    Ghafouri-Fard S; Khoshbakht T; Taheri M; Shojaei S
    Front Oncol; 2021; 11():779483. PubMed ID: 35096580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.